Bollard Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,958
Closed -$30K 434
2022
Q1
$30K Hold
1,958
﹤0.01% 373
2021
Q4
$30K Hold
1,958
﹤0.01% 378
2021
Q3
$17K Hold
1,958
﹤0.01% 398
2021
Q2
$20K Hold
1,958
﹤0.01% 393
2021
Q1
$23K Hold
1,958
﹤0.01% 389
2020
Q4
$18K Hold
1,958
﹤0.01% 392
2020
Q3
$12K Hold
1,958
﹤0.01% 407
2020
Q2
$17K Buy
+1,958
New +$16.9K ﹤0.01% 417

Other funds holding NPTN

Bollard Group's NPTN Position: Q2 2022 in Review

Bollard Group sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 1,958 shares — an estimated $30K sold.

Bollard Group first reported a position in NPTN in Q2 2020 and held it in 8 quarters. The position peaked at $30K in Q1 2022. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.

  • Bollard Group reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
  • Bollard Group sold 1,958 NEOPHOTONICS CORP shares in Q2 2022, an estimated $30K.
  • Bollard Group first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 8 quarters.
  • Bollard Group's NEOPHOTONICS CORP position peaked at $30K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.